Answers are grounded in this paper and cite their sources.
Investigates FOXO3 inhibition by JBIR-141 analogues in leukemia, highlighting potential therapeutic pathways.
High Resolution Image Download MS PowerPoint Slide The total synthesis of JBIR-141 and its analogues was achieved through a convergent assembly of three fragments. This synthesis successfully addressed several challenges arising from a highly acid-sensitive oxazoline, a reactive nitrosohydroxyamino group, and an epimerization-prone tetramic acid. The developed synthetic route enabled access to 25-methyl/17-methyl derivatives as potent/stabilized FOXO3 inhibitors. This study provides a robust platform for structure–activity relationship studies and future target identification in chronic myelogenous leukemia therapeutics.
No takes yet. Share an insight, caveat, or question.
Ban et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: